Sample Matrix Expansion Study
2025.06 – Present
Sample Matrix Expansion Study for a Commercialized Extraction Product
Role: Project Lead
Scale
Commercialized product expansion project aimed at extending application coverage and supporting future product lineup growth.
Key Results
Leading feasibility research for expanding the applicable sample types of an existing extraction product, including experimental design, performance evaluation planning, and application scope review. Currently in progress.
Next-Generation Extraction Platform Introduction Project
2025.03 – 2025.09
Feasibility Study for Introducing a New Extraction Equipment Platform
Role: Project Lead
Scale
Research project aimed at identifying and evaluating new extraction equipment platforms to support future business growth and product portfolio expansion.
Key Results
Led the evaluation of new extraction equipment candidates, including technical feasibility review and vendor communication. Prepared key documentation for equipment introduction, including User Requirement Specification (URS). The project is currently on hold due to internal business prioritization.
Critical VOC Resolution for Key Commercialized Extraction Products
2025.10 – 2026.06
VOC Resolution for Two Commercialized Extraction Products
Role: Project Lead
Scale
Customer complaint resolution project for two commercialized extraction products, including one major product accounting for more than 20% of total extraction product sales.
Key Results
Led root cause analysis and corrective actions for two long-standing VOC issues that had persisted for over one and two years. Successfully resolved both issues, including one major sales product with previously unclear root cause. No additional VOC cases have been reported to date after implementation of corrective actions.
Proprietary Fluorescent Oligonucleotide Platform Development
2024.01 – 2025.02
Development of Proprietary Fluorescent Oligonucleotide Synthesis Technology
Role: Co-researcher
Scale
Development project for proprietary fluorescent oligonucleotides incorporating multiple fluorophore and quencher combinations based on the company’s core technology.
Key Results
Developed synthesis methods for 15 fluorescent oligonucleotide combinations using 5 fluorophores and 3 quenchers. Contributed to synthesis process development, condition optimization, and technical feasibility verification. Participated in patent preparation, leading to completed domestic patent application KR 10-2025-0052603 (Unpublished).
Patent
KR 10-2025-0052603 (Filing Date: 2025.04.22, Unpublished). Inventors: Chanuk Jeong et al.
End-to-End Oligonucleotide Synthesis Platform Establishment
2020.10 – 2023.12
Establishment of Oligonucleotide Synthesis, Purification, and Analysis Platform
Role: Co-researcher
Scale
Platform establishment project for building the company’s oligonucleotide synthesis capabilities, including synthesis, purification, analysis, and documentation workflows.
Key Results
Established synthesis, purification, and analytical workflows from small-scale experiments to large-scale production. Developed core protocols for standard oligonucleotides and proprietary technology-based oligonucleotides. Contributed to technical documentation and process establishment supporting the company’s ISO 13485 certification.